Stock listing
NASDAQ:LXEO Lexeo Therapeutics, Inc. Stock
Home listing (NASDAQ) of Lexeo Therapeutics, Inc.
Follow Lexeo Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:LXEO
$3.06 USD -0.08 (-2.5%)
Close on Nov 2, 2026
- Day range
- $2.99 – $3.18 USDNov 2, 2026
- Volume
- 1.22M sharesNov 2, 2026
- Market cap
- $251.2M USDAt the close on Nov 2, 2026 · price × 82.09M shares outstanding
- 52-week range
- $2.55 – $10.99 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $4.85M USDMedian day 1.08M shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:LXEO · Home | $3.06 USD | -0.08 (-2.5%) | 1,218,590 | $3.16 | $3.18 | $2.99 | $3.14 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:LXEO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.06 | -0.08 | -2.5% | $3.16 | $3.18 | $2.99 | 1,218,590 | |
| $3.14 | +0.08 | +2.6% | $3.10 | $3.295 | $2.90 | 1,001,519 | |
| $3.06 | -0.07 | -2.2% | $3.16 | $3.375 | $3.05 | 1,046,020 | |
| $3.13 | +0.26 | +9.1% | $2.85 | $3.14 | $2.78 | 1,198,286 | |
| $2.87 | +0.17 | +6.3% | $2.71 | $2.935 | $2.65 | 2,684,072 | |
| $2.70 | -0.10 | -3.6% | $2.80 | $2.825 | $2.675 | 1,162,581 | |
| $2.80 | -0.09 | -3.1% | $2.87 | $2.965 | $2.73 | 619,400 | |
| $2.89 | -0.11 | -3.7% | $2.98 | $3.12 | $2.89 | 492,500 | |
| $3.00 | -0.02 | -0.7% | $3.03 | $3.09 | $2.97 | 1,080,300 | |
| $3.02 | +0.26 | +9.4% | $2.76 | $3.055 | $2.71 | 1,275,700 | |
| $2.76 | +0.12 | +4.5% | $2.65 | $2.81 | $2.55 | 1,863,100 | |
| $2.64 | -0.12 | -4.3% | $2.75 | $2.84 | $2.63 | 2,506,700 | |
| $2.76 | +0.13 | +4.9% | $2.66 | $2.83 | $2.61 | 1,303,800 | |
| $2.63 | -0.11 | -4.0% | $2.70 | $2.785 | $2.56 | 1,943,400 | |
| $2.74 | -0.30 | -9.9% | $3.09 | $3.09 | $2.74 | 1,586,500 | |
| $3.04 | -0.19 | -5.9% | $3.22 | $3.22 | $3.04 | 1,048,300 | |
| $3.23 | +0.02 | +0.6% | $3.21 | $3.34 | $3.115 | 961,400 | |
| $3.21 | -0.10 | -3.0% | $3.27 | $3.28 | $3.111 | 2,546,100 | |
| $3.31 | +0.01 | +0.3% | $3.27 | $3.465 | $3.22 | 1,195,100 | |
| $3.30 | -0.11 | -3.2% | $3.43 | $3.43 | $3.17 | 1,538,800 | |
| $3.41 | -0.12 | -3.4% | $3.56 | $3.655 | $3.37 | 1,858,000 | |
| $3.53 | -0.09 | -2.5% | $3.66 | $3.689 | $3.495 | 2,592,100 | |
| $3.62 | +0.24 | +7.1% | $3.38 | $3.68 | $3.295 | 2,886,500 | |
| $3.38 | -0.04 | -1.2% | $3.44 | $3.589 | $3.275 | 3,053,800 | |
| $3.42 | +0.28 | +8.9% | $3.14 | $3.59 | $2.98 | 6,560,000 | |
| $3.14 | -0.17 | -5.1% | $3.27 | $3.29 | $3.14 | 1,256,700 | |
| $3.31 | -0.08 | -2.4% | $3.40 | $3.455 | $3.27 | 1,007,100 | |
| $3.39 | -0.13 | -3.7% | $3.50 | $3.50 | $3.33 | 1,484,600 | |
| $3.52 | -0.55 | -13.5% | $4.07 | $4.09 | $3.455 | 2,423,100 | |
| $4.07 | -0.01 | -0.2% | $4.31 | $4.33 | $4.035 | 3,092,300 | |
| $4.08 | -0.12 | -2.9% | $4.24 | $4.335 | $4.04 | 854,800 | |
| $4.20 | +0.02 | +0.5% | $4.16 | $4.225 | $4.059 | 2,287,800 | |
| $4.18 | +0.02 | +0.5% | $4.27 | $4.38 | $4.14 | 1,099,100 | |
| $4.16 | +0.03 | +0.7% | $4.16 | $4.22 | $4.09 | 619,500 | |
| $4.13 | -0.08 | -1.9% | $4.18 | $4.275 | $4.01 | 888,400 | |
| $4.21 | -0.04 | -0.9% | $4.31 | $4.36 | $4.18 | 1,263,700 | |
| $4.25 | -0.11 | -2.5% | $4.43 | $4.475 | $4.205 | 1,490,800 | |
| $4.36 | -0.12 | -2.7% | $4.43 | $4.44 | $4.31 | 420,900 | |
| $4.48 | -0.28 | -5.9% | $4.72 | $4.805 | $4.48 | 311,600 | |
| $4.76 | -0.13 | -2.7% | $4.82 | $4.87 | $4.66 | 357,800 | |
| $4.89 | +0.05 | +1.0% | $4.76 | $4.99 | $4.76 | 296,400 | |
| $4.84 | +0.06 | +1.3% | $4.80 | $4.92 | $4.67 | 313,300 | |
| $4.78 | +0.08 | +1.7% | $4.76 | $4.96 | $4.65 | 468,400 | |
| $4.70 | -0.06 | -1.3% | $4.70 | $4.77 | $4.564 | 420,500 | |
| $4.76 | -0.10 | -2.1% | $4.82 | $4.82 | $4.62 | 472,000 | |
| $4.86 | -0.13 | -2.6% | $4.96 | $4.96 | $4.73 | 663,600 | |
| $4.99 | -0.02 | -0.4% | $4.97 | $5.09 | $4.885 | 1,105,700 | |
| $5.01 | -0.12 | -2.3% | $5.10 | $5.11 | $4.91 | 690,000 | |
| $5.13 | +0.21 | +4.3% | $4.97 | $5.13 | $4.94 | 937,400 | |
| $4.92 | +0.04 | +0.8% | $4.88 | $4.965 | $4.70 | 518,500 | |
| $4.88 | -0.18 | -3.6% | $5.12 | $5.204 | $4.84 | 509,600 | |
| $5.06 | -0.31 | -5.8% | $5.29 | $5.355 | $4.90 | 1,113,600 | |
| $5.37 | +0.44 | +8.9% | $5.07 | $5.405 | $5.05 | 941,900 | |
| $4.93 | -0.05 | -1.0% | $4.94 | $5.05 | $4.825 | 649,800 | |
| $4.98 | +0.14 | +2.9% | $4.83 | $5.026 | $4.82 | 913,800 | |
| $4.84 | -0.12 | -2.4% | $4.98 | $4.98 | $4.72 | 676,600 | |
| $4.96 | +0.09 | +1.8% | $4.95 | $5.015 | $4.73 | 1,109,500 | |
| $4.87 | +0.09 | +1.9% | $4.84 | $5.075 | $4.70 | 1,630,300 | |
| $4.78 | +0.15 | +3.2% | $4.66 | $4.89 | $4.54 | 1,332,477 | |
| $4.63 | -0.18 | -3.7% | $4.79 | $4.85 | $4.60 | 722,071 | |
| $4.81 | +0.26 | +5.7% | $4.60 | $4.825 | $4.54 | 1,080,200 | |
| $4.55 | +0.10 | +2.2% | $4.57 | $4.705 | $4.40 | 1,463,800 | |
| $4.45 | +0.04 | +0.9% | $4.50 | $4.69 | $4.36 | 910,500 | |
| $4.41 | +0.21 | +5.0% | $4.22 | $4.49 | $4.22 | 916,800 | |
| $4.20 | +0.07 | +1.7% | $4.15 | $4.205 | $3.99 | 667,200 |
- Ticker
- NASDAQ:LXEO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 2, 2026
Lexeo Therapeutics to Present Multiple Oral and Poster Presentations at Key Scientific Conferences in November
Latest deck · Sep 22, 2026
Corporate Update (September 2026)
Corporate update · 14 slides
Latest news
Lexeo Therapeutics to Present Multiple Oral and Poster Presentations at Key Scientific Conferences in November
Nov 2, 2026
Closed $3.06 (-2.5%) on Nov 2, 2026
Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACM
Oct 19, 2026
Closed $2.76 (+4.5%) on Oct 19, 2026
Lexeo Therapeutics to Participate in the Chardan Healthcare Conference
Oct 8, 2026
Closed $3.21 (-3.0%) on Oct 8, 2026
Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS)
Oct 1, 2026
Closed $3.62 (+7.1%) on Oct 1, 2026
Apertura Gene Therapy to Provide Lexeo Therapeutics Access to TfR1 CapX™ for Program Designed to Treat Friedreich Ataxia
Sep 23, 2026
Closed $3.52 (-13.5%) on Sep 23, 2026
Lexeo Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum
Sep 23, 2026
Closed $3.52 (-13.5%) on Sep 23, 2026
Lexeo Therapeutics Enters Into Agreement to Acquire Mantle Therapeutics and Announces Multiple New Strategic Collaborations to Expand Leadership in Friedreich Ataxia
Sep 22, 2026
Closed $4.07 (-0.2%) on Sep 22, 2026
Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September
Sep 2, 2026
Closed $4.78 (+1.7%) on Sep 2, 2026
Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights
Aug 12, 2026
Closed $4.87 (+1.9%) on Aug 12, 2026
Decks
Corporate Update (September 2026)
Corporate update · 14 slides · Sep 22, 2026
Investor Presentation (August 2026)
Investor deck · 35 slides · Aug 12, 2026
Corporate Update (June 2026)
Corporate update · 16 slides · Jun 15, 2026
Investor Presentation (June 2026)
Investor deck · 31 slides · Jun 15, 2026
Lexeo Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 24 in the last 12 months · 53 in all · newest Nov 2, 2026 · oldest 2023
- Decks
- 18 decks · latest Sep 22, 2026
Where Lexeo Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:LXEO · Home listing · This page | NASDAQ | United States | USD |
| BOATS:LXEO | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Lexeo Therapeutics, Inc.